1 Liu J, Bai R, Chai Z, Cooper ME, Zimmet PZ, et al. (2022). Low- and middle-income countries demonstrate rapid growth of
type 2 diabetes: an analysis based on Global Burden of Disease 1990-2019 data. Diabetologia 65: 1339-52.
2 Dunachie S, Chamnan P (2019). The double burden of diabetes and global infection in low and middle-income countries. Trans
R Soc Trop Med Hyg 113: 56-64.
3 Roglic G, Unwin N (2010). Mortality attributable to diabetes: Estimates for the year 2010. Diabetes Res Clin Pract 87: 15-9.
4 IDF Diabetes Atlas (2019). Brussels: International Diabetes Federation. 9th ed.
5 Lind M, Garcia-Rodriguez LA, Booth GL, et al. (2013). Mortality trends in patients with and without diabetes in Ontario,
Canada and the UK from 1996 to 2009: a population-based study. Diabetologia 56: 2601-8.
6 Færch K, Carstensen B, Almdal TP, Jørgensen ME (2014). Improved survival among patients with complicated type 2 diabetes
in Denmark: a prospective study (2002-2010) J Clin Endocrinol Metab 99: E642-6.
7 Gregg EW, Cheng YJ, Saydah S, et al. (2012). Trends in death rates among U.S. adults with and without diabetes between 1997
and 2006: findings from the National Health Interview Survey. Diabetes Care 35: 1252-7.
8 Zhou M, Wang H, Zeng X, et al. (2019). Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a
systematic analysis for the global burden of disease study 2017. Lancet 394: 1145-58.
9 Shaw JE, Sicree RA, Zimmet PZ (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin
Pract 87: 4-14.
10 Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, et al. (2018). Global Economic Burden of Diabetes in Adults:
Projections from 2015 to 2030. Diabetes Care 41: 963-70.
11 Aikaeli F, Njim T, Id SG, Moyo F, Alam U, et al. (2022). Prevalence of microvascular and macrovascular complications of
diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: A systematic review and meta-analysis. PLOS
Global Public Health 2: e0000599.
12George C, Echouffo-Tcheugui JB, Jaar BG, Okpechi IG, Kengne AP (2022). The need for screening, early diagnosis, and
prediction of chronic kidney disease in people with diabetes in low- and middle-income countries—a review of the current
literature. BMC Med 20: 1-12.
13 Mufunda J, Chatora R, Ndambakuwa Y, Nyarango P, Kosia A, et al. (2006). Emerging noncommunicable disease epidemic in
Africa: preventive measures from the WHO Regional Office for Africa. Ethn Dis 16: 521-6.
14 de Graft AA, Addo J, Ofei F, Bosu WK, Agyemang C (2012). Ghana’s burden of chronic non-communicable diseases: future
directions in research, practice and policy. Ghana Med J 46: 1-3.
15Pastakia SD, Pekny CR, Manyara SM, Fischer L (2017). Diabetes in sub-Saharan Africa - from policy to practice to progress:
targeting the existing gaps for future care for diabetes. Diabetes Metab Syndr Obes 10: 247-63.
16 International Diabetes Federation. IDF Diabetes Atlas, 7th ed
17WHO (2015) WHO STEP wise approach to surveillance (STEPS). Benin. Geneva.
18 Godman B, Basu D, Pillay Y, Mwita JC, Rwegerera GM, et al. (2020). Review of Ongoing Activities and Challenges to Improve
the Care of Patients with Type 2 Diabetes Across Africa and the Implications for the Future. Front Pharmacol 11: 108.
19 Alassani A, Dovonou C, Gninkoun J, Wanvoegbe A, Attinsounon C, et al. (2017). Perceptions et pratiques des diabetiques face
au diabete sucre au Centre National Hospitalier et Universitaire Hubert Koutoucou Maga (CNHU-HKM) de Cotonou. Mali Med
32 : 23-7.
20 Wanvoegbe FA, Agbodande KA, Alassani A, Aviansou A, Gninkoun J, et al. (2018). Evaluation de l’observance thérapeutique
chez les diabétiques au Bénin. Med Afr noire 65 : 355-61.
21 Houngla MFN, (2020). Pratiques alimentaires et gestion du diabète chez les diabétiques suivis au Centre National Hospitalier
et Universitaire et à la Banque d’insuline de Cotonou au Bénin. University of Montreal. Master Thesis.
22 Adeya G, Bigirimana A, Cavanaugh K, Franco LM (2011). Rapid assessment of the health system in Benin. International
Development Health Journal.
23 Institute for Health Metrics and Evaluation (IHME) (2017) Benin.
24 GBD 2017 Causes of Death Collaborators. (2018) Global, regional, and national age-sex-specific mortality for 282 causes of
death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:
1736-88.
25 WHO Global Report. (2016) Global Report on Diabetes.
26 Chen L, Magliano DJ, Balkau B, Colagiuri S, Zimmet PZ, et al. (2010). AUSDRISK: An Australian Type 2 Diabetes Risk
Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Medical Journal of Australia. 192: 274.
27 Thomas C, Hyppönen E, Power C (2006). Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and
body mass index. Arch Intern Med 166: 682-8.
28 Gray LJ, Taub NA, Khunti K, Gardiner E, Hiles S et al. (2010). The Leicester Risk Assessment score for detecting undiagnosed
Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med 27: 887-95.
29 Gabriel R, Acosta T, Florez K, Anillo L, Navarro E, et al. (2021). Validation of the Finnish Type 2 Diabetes Risk Score
(FINDRISC) with the OGTT in Health Care Practices in Europe. Diabetes Res Clin Pract 178: 108976.
30 Ekure E, Ovenseri-Ogbomo G, Osuagwu UL, Agho KE, Ekpenyong BN, et al. (2022). A systematic review of diabetes risk
assessment tools in sub-Saharan Africa. Int J Diabetes Dev Ctries 42: 380-93.
31 Metonnou-Adanhoume CG, Agueh V, Azandjeme CS, Sossa CJ, Kpozehouen A, et al. (2019). Optimal Threshold of the
Finnish Diabetes Risk Score (Findrisc) for Screening At-risk Adults in an African Population in Southern Benin. Univers J Public
Health 7: 63-72.
32 American Diabetes Association. (2012). Diagnosis and Classification of Diabetes Mellitus 35: 64-71.
33 Sodjinou R, Agueh V, Fayomi B, Delisle H (2007). Dietary patterns of urban adults in Benin: relationship with overall diet
quality and socio-demographic characteristics. European Journal of Clinical Nutrition 63: 222-8.
34 Delisle H, Ntandou-Bouzitou G, Agueh V, Sodjinou R, Fayomi B (2012). Urbanisation, nutrition transition and
cardiometabolic risk: The Benin study. BJN 28: 1534-44.
35Miles M, Huberman M (1994). Qualitative Data Analysis: An Expanded Sourcebook. 2nd ed. Thousand Oaks, Calif: Sage.
36 Rolka DB, Venkat Narayan KM, Thompson TJ, Goldman D, Llndenmayer J, et al. (2001). Performance of Recommended
Screening Tests for Undiagnosed Diabetes and Dysglycemia. Diabetes Care 24: 1899-903.
37 Ministère du Développement (2019) de l’Analyse Économique et de la Prospective (MDAEP) et Institute National de la
Statistique de l’Analyse Économique (INSAE). République Du Bénin Cinquième Enquête Démographique et de Santé au Bénin
(EDSB-V) INSAE/Benin and ICF : Cotonou, Bénin.
38 Rowan CP, Miadovnik LA, Riddell MC, Rotondi MA, Gledhill N, et al. (2014). Identifying persons at risk for developing type 2
diabetes in a concentrated population of high risk ethnicities in Canada using a risk assessment questionnaire and point-of-care
capillary blood HbA1cmeasurement. BMC Public Health 14: 1-9.
39 Leal J, Ahrabian D, Davies MJ, Gray LJ, Khunti K, et al. (2017). Cost-effectiveness of a pragmatic structured education
intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let’s Prevent Diabetes cluster-randomised
controlled trial. BMJ Open 7: e013592.
40 Ross D Feldman, Norman Campbell, Pierre Larochelle, Peter Bolli, Ellen D, et al. (1999). 1999 Canadian recommendations for
the management of hypertension. Can Med Assoc J 161: S1-17
41 International Diabetes Foundation (2006). The IDF consensus worldwide definition of the metabolic syndrome. Brussels,
Belgium.
42WHO (2011). Use of Glycated Hemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO
Consultation. Geneva: World Health Organization.
43Ganz ML, Wintfeld N, Li Q, Alas V, Langer J, et al. (2014). The association of body mass index with the risk of type 2 diabetes:
A case-control study nested in an electronic health records system in the United States. Diabetol Metab Syndr 6: 1-8.
44 Hemmingsen B, Gimenez-Perez G, Mauricio D, Roqué i Figuls M, Metzendorf MI, et al. (2017). Diet, physical activity or both
for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2
diabetes mellitus. Cochrane Database of Systematic Reviews.
45 US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, et al. (2021). Screening
for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA 326: 736-43.
46 Cederberg H, Stančáková A, Kuusisto J, Laakso M, Smith U (2015). Family history of type 2 diabetes increases the risk of both
obesity and its complications: is type 2 diabetes a disease of inappropriate lipid storage? J Intern Med 277: 540-1.
47 Kyrou I, Tsigos C, Mavrogianni C, Cardon G, van Stappen V, et al. (2020). Sociodemographic and lifestyle-related risk factors
for identifying vulnerable groups for type 2 diabetes: A narrative review with emphasis on data from Europe. BMC Endocr Disord
20: 1-13.
48 Hajian-Tilaki K (2013). Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J
Intern Med 4: 627-35.
49 Canadian Task Force on Preventive Health Care (2012). Recommendations on screening for type 2 diabetes in adults.
Canadian Medical Association Journal 16: 15.
50 National Institute for Health and Clinical Excellence (2012). Preventing Type 2 Diabetes: Risk Identification and Interventions
for Individuals at High Risk, NICE Public Health Guidance 38: 22.
51 Kengne AP, Beulens JW, Peelen LM, Moons KG, van der Schouw YT, et al. (2014). Non-invasive risk scores for prediction of
type 2 diabetes (EPIC-InterAct): a validation of existing models. Lancet Diabetes Endocrinol 2: 19-29.
52 Noble D, Mathur R, Dent T, Meads C, Greenhalgh T (2011). Risk models and scores for type 2 diabetes: systematic review.
BMJ 343: d7163.
53 Sacks DB (2011). A1C versus glucose testing: a comparison. Diabetes Care 34: 518-23.
54 Stommel M, Schoenborn C (2009). Accuracy and usefulness of BMI measures based on self-reported weight and height:
findings from the NHANES & NHIS 2001–2006. BMC Public Health 9 : 421.
55 Khunti K, Taub N, Webb D, Srinivasan B, Stockman J, et al. (2012). Validity of self-assessed waist circumference in a multiethnicUK population. Diabet Med 29: 404-9.
56 Klonoff DC (2020). Hemoglobinopathies and Hemoglobin A1c in Diabetes Mellitus. J Diabetes Sci Technol. 14: 3-7.
57 Zohoun A, Baglo Agbodande T, Zohoun L, Anani L (2020). Prevalence of hemoglobin abnormalities in an apparently healthy
population in Benin. Hematol Transfus Cell Ther 42: 145-9.